Analyst Ratings for PTC Therapeutics (PTCT)
PTCT Rating Summary
PTCT Price Target Summary
- Highest: $200.00 (Rosenblatt)
- Lowest: $55.00 (Goldman Sachs)
- Average: $102.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$102.25 (+68.8%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$102.25 (+68.8%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | Truist Securities | Danielle Brill | New Coverage | Hold (N/A) |
62.00 (N/A) |
60.99 (60.59) |
-0.66% | Details |
| 9/14/2026 | Leerink | N/A | New Coverage | Outperform (N/A) |
98.00 (N/A) |
66.06 (60.59) |
-8.28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
